4.8 Article

Tunable electroconductive decellularized extracellular matrix hydrogels for engineering human cardiac microphysiological systems

Journal

BIOMATERIALS
Volume 272, Issue -, Pages -

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2021.120764

Keywords

Hybrid materials; Cardiac tissue engineering; Bioprinting; Decellularized extracellular matrix; Graphene oxide

Funding

  1. National Institutes of Health [UH3 TR003519M, R01 HL146436, R01 HL135143, R21 EB020132, UG3 EB028094, TL1 TR002318, F32 HL126332]
  2. National Science Foundation [ECC-1542101, NNCI-1542101, 1337840, 0335765, CMMI-1661730]
  3. University of Washington
  4. Molecular Engineering & Sciences Institute
  5. Clean Energy Institute
  6. National Institutes of Health
  7. Washington Research Foundation
  8. M. J. Murdock Charitable Trust
  9. Altatech
  10. ClassOne Technology
  11. GCE Market
  12. Google
  13. SPTS
  14. American Heart Association [16PRE30760018]

Ask authors/readers for more resources

Hybrid hydrogels composed of decellularized porcine myocardial extracellular matrix (dECM) and reduced graphene oxide (rGO) were developed to improve the functionality of cardiomyocytes. These hydrogels can also be used as bioinks to print cardiac tissues in a high-throughput manner. Modulating the composition and properties of the materials can enhance the electrophysiological function of cardiac tissues.
Cardiomyocytes differentiated from human induced pluripotent stem cells (hiPSCs) offer tremendous potential when used to engineer human tissues for drug screening and disease modeling; however, phenotypic immaturity reduces assay reliability when translating in vitro results to clinical studies. To address this, we have developed hybrid hydrogels comprised of decellularized porcine myocardial extracellular matrix (dECM) and reduced graphene oxide (rGO) to provide a more instructive microenvironment for proper cell and tissue development. A tissue-specific protein profile was preserved post-decellularization, and through the modulation of rGO content and degree of reduction, the mechanical and electrical properties of the hydrogels could be tuned. Engineered heart tissues (EHTs) generated using dECM-rGO hydrogel scaffolds and hiPSC-derived cardiomyocytes exhibited significantly increased twitch forces and had increased expression of genes that regulate contractile function. Improvements in various aspects of electrophysiological function, such as calcium-handling, action potential duration, and conduction velocity, were also induced by the hybrid biomaterial. dECM-rGO hydrogels could also be used as a bioink to print cardiac tissues in a high-throughput manner, and these tissues were utilized to assess the proarrhythmic potential of cisapride. Action potential prolongation and beat interval irregularities was observed in dECM-rGO tissues at clinical doses of cisapride, indicating that the enhanced electrophysiological function of these tissues corresponded well with a capability to produce physiologically relevant drug responses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available